| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
121,101 |
103,447 |
$6.69M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
24,293 |
18,617 |
$1.47M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
86,434 |
73,761 |
$1.19M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
28,811 |
21,976 |
$953K |
| 84443 |
Thyroid stimulating hormone (TSH) |
82,029 |
78,097 |
$863K |
| 80053 |
Comprehensive metabolic panel |
135,058 |
121,468 |
$825K |
| 80061 |
Lipid panel |
72,930 |
69,577 |
$594K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
31,392 |
30,051 |
$564K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
116,398 |
101,340 |
$523K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
19,380 |
18,393 |
$344K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
15,470 |
14,727 |
$340K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
15,443 |
14,702 |
$340K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
53,946 |
51,505 |
$295K |
| 36415 |
Collection of venous blood by venipuncture |
199,759 |
152,551 |
$219K |
| 87481 |
|
9,970 |
6,197 |
$202K |
| 87522 |
Neg quan hep c or qual rna |
5,871 |
5,580 |
$201K |
| 86803 |
|
20,983 |
19,816 |
$192K |
| 82728 |
|
20,677 |
19,540 |
$190K |
| 82607 |
|
20,595 |
19,518 |
$175K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
52,454 |
39,838 |
$152K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,006 |
3,692 |
$151K |
| 86003 |
|
2,838 |
2,544 |
$149K |
| 86780 |
|
13,404 |
12,454 |
$143K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
6,607 |
6,302 |
$136K |
| 87511 |
|
6,494 |
6,175 |
$134K |
| 85027 |
|
40,053 |
35,522 |
$133K |
| 82746 |
|
14,549 |
13,877 |
$130K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,642 |
1,584 |
$130K |
| 84439 |
|
20,346 |
19,322 |
$129K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
6,547 |
6,352 |
$128K |
| 87536 |
|
3,120 |
2,994 |
$127K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
4,915 |
2,588 |
$126K |
| 87340 |
|
15,481 |
14,628 |
$125K |
| 86706 |
|
13,328 |
12,761 |
$118K |
| 83550 |
|
19,693 |
18,716 |
$111K |
| 86704 |
|
11,502 |
11,008 |
$108K |
| 84403 |
|
6,456 |
6,066 |
$108K |
| 86480 |
|
3,131 |
3,031 |
$101K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
23,913 |
21,749 |
$101K |
| 88142 |
|
5,527 |
5,375 |
$98K |
| 83970 |
|
4,605 |
4,313 |
$91K |
| 86481 |
|
2,180 |
2,117 |
$91K |
| 83540 |
|
20,691 |
19,606 |
$86K |
| 87902 |
|
1,110 |
1,067 |
$79K |
| 83655 |
|
6,713 |
6,570 |
$77K |
| 87070 |
|
10,750 |
10,199 |
$70K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,800 |
2,553 |
$68K |
| 83735 |
|
24,555 |
18,065 |
$67K |
| 82670 |
|
2,889 |
2,726 |
$64K |
| 84153 |
|
5,362 |
5,123 |
$64K |
| 86618 |
|
5,900 |
5,585 |
$62K |
| 86762 |
|
5,018 |
4,644 |
$58K |
| 84702 |
|
4,808 |
3,928 |
$58K |
| 86787 |
|
5,238 |
4,924 |
$56K |
| 82784 |
|
6,490 |
5,935 |
$54K |
| 83001 |
|
3,422 |
3,278 |
$51K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,843 |
1,634 |
$48K |
| 87186 |
|
10,669 |
9,920 |
$47K |
| 86140 |
|
13,713 |
11,920 |
$46K |
| 83880 |
|
3,943 |
3,549 |
$45K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,928 |
1,855 |
$44K |
| 84146 |
|
2,850 |
2,693 |
$43K |
| 80074 |
|
1,227 |
1,179 |
$42K |
| 85610 |
|
27,372 |
15,215 |
$41K |
| 86038 |
|
4,532 |
4,262 |
$39K |
| 84402 |
|
2,313 |
2,214 |
$33K |
| 82043 |
|
10,997 |
10,471 |
$32K |
| 87077 |
|
11,221 |
10,381 |
$32K |
| 86235 |
|
907 |
783 |
$31K |
| 83516 |
|
3,672 |
2,740 |
$31K |
| 87517 |
|
1,034 |
986 |
$31K |
| 82785 |
|
2,307 |
2,193 |
$31K |
| 83002 |
|
1,945 |
1,840 |
$30K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
375 |
299 |
$28K |
| 80076 |
|
5,309 |
4,959 |
$25K |
| 84480 |
|
2,389 |
2,267 |
$24K |
| 87209 |
|
1,704 |
1,527 |
$23K |
| 86765 |
|
2,141 |
2,074 |
$23K |
| 86735 |
|
2,110 |
2,037 |
$23K |
| 84481 |
|
1,960 |
1,833 |
$22K |
| 86617 |
|
926 |
885 |
$21K |
| 86850 |
|
6,680 |
5,667 |
$21K |
| 82274 |
|
2,426 |
2,283 |
$21K |
| 85652 |
|
11,666 |
10,177 |
$21K |
| 86800 |
|
1,868 |
1,790 |
$20K |
| 87493 |
|
1,659 |
1,580 |
$20K |
| 81001 |
|
13,834 |
12,562 |
$20K |
| 86376 |
|
1,673 |
1,600 |
$20K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
454 |
416 |
$19K |
| 80164 |
|
3,824 |
3,471 |
$19K |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
2,687 |
2,609 |
$19K |
| 82533 |
|
1,570 |
1,435 |
$18K |
| 83690 |
|
4,106 |
3,877 |
$18K |
| 87046 |
|
1,078 |
1,035 |
$18K |
| 83020 |
|
1,721 |
1,615 |
$18K |
| 86334 |
|
2,167 |
1,524 |
$17K |
| 84165 |
|
3,302 |
2,923 |
$17K |
| 82105 |
|
1,471 |
1,359 |
$17K |
| 84100 |
|
6,942 |
5,655 |
$17K |
| 87338 |
|
1,889 |
1,851 |
$17K |
| 86160 |
|
1,126 |
1,007 |
$16K |
| 86364 |
|
2,203 |
2,085 |
$16K |
| 86708 |
|
1,725 |
1,635 |
$16K |
| 83721 |
|
2,776 |
2,635 |
$16K |
| 86900 |
|
6,661 |
5,686 |
$15K |
| 86360 |
|
1,543 |
1,479 |
$15K |
| 86901 |
|
6,648 |
5,665 |
$15K |
| 81511 |
|
158 |
153 |
$15K |
| 82570 |
|
5,399 |
4,966 |
$14K |
| 82950 |
|
3,237 |
3,093 |
$14K |
| 86431 |
|
3,430 |
3,254 |
$14K |
| 83993 |
|
870 |
835 |
$13K |
| 86359 |
|
1,550 |
1,484 |
$13K |
| 86200 |
|
1,394 |
1,317 |
$12K |
| 80197 |
|
4,701 |
3,178 |
$12K |
| 84305 |
|
760 |
744 |
$12K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
515 |
490 |
$12K |
| 87205 |
|
4,144 |
3,895 |
$11K |
| 86696 |
|
729 |
689 |
$10K |
| 83883 |
|
1,160 |
1,051 |
$10K |
| 84460 |
|
3,196 |
3,027 |
$10K |
| 84156 |
|
5,373 |
4,888 |
$10K |
| 83615 |
|
2,706 |
1,943 |
$10K |
| 82977 |
|
1,776 |
1,642 |
$9K |
| 83010 |
|
1,048 |
966 |
$9K |
| 80050 |
General health panel |
715 |
639 |
$9K |
| 87177 |
|
1,347 |
1,188 |
$9K |
| 80069 |
|
2,735 |
2,442 |
$9K |
| 82150 |
|
2,180 |
2,056 |
$9K |
| 84425 |
|
813 |
777 |
$9K |
| 82550 |
|
2,448 |
2,169 |
$9K |
| 84550 |
|
3,773 |
3,288 |
$9K |
| 80178 |
|
2,504 |
2,249 |
$8K |
| 80175 |
|
1,678 |
1,556 |
$8K |
| 86665 |
|
669 |
310 |
$8K |
| 87427 |
|
1,057 |
1,017 |
$8K |
| 83921 |
|
840 |
815 |
$8K |
| 81003 |
|
6,734 |
6,343 |
$8K |
| 87799 |
|
623 |
487 |
$8K |
| 83520 |
|
754 |
694 |
$7K |
| 85730 |
|
1,752 |
1,613 |
$7K |
| 86695 |
|
730 |
690 |
$7K |
| 82248 |
|
2,222 |
1,901 |
$7K |
| 86682 |
|
570 |
530 |
$7K |
| 87045 |
|
1,080 |
1,033 |
$7K |
| 85045 |
|
2,293 |
2,016 |
$6K |
| 83525 |
|
662 |
631 |
$6K |
| 86225 |
|
599 |
554 |
$6K |
| 84450 |
|
1,893 |
1,787 |
$5K |
| 82103 |
|
561 |
509 |
$5K |
| 80159 |
|
1,377 |
1,120 |
$5K |
| 80177 |
|
1,310 |
1,206 |
$5K |
| 86663 |
|
444 |
413 |
$5K |
| 82947 |
|
1,950 |
1,841 |
$5K |
| 82652 |
|
202 |
193 |
$5K |
| 88184 |
|
157 |
128 |
$4K |
| 86664 |
|
348 |
323 |
$4K |
| 84155 |
|
2,691 |
2,440 |
$4K |
| 82565 |
|
2,079 |
1,873 |
$4K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
20 |
20 |
$4K |
| 84436 |
|
1,084 |
1,023 |
$4K |
| 82040 |
|
2,975 |
2,686 |
$4K |
| 83519 |
|
268 |
249 |
$4K |
| 86709 |
|
392 |
376 |
$4K |
| 86039 |
|
442 |
423 |
$4K |
| 85018 |
|
2,444 |
2,239 |
$4K |
| 87634 |
|
131 |
123 |
$3K |
| 84144 |
|
219 |
201 |
$3K |
| 82247 |
|
1,050 |
905 |
$3K |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
709 |
679 |
$3K |
| 84134 |
|
335 |
291 |
$3K |
| 83021 |
|
152 |
149 |
$2K |
| 82951 |
|
222 |
213 |
$2K |
| 82310 |
|
938 |
836 |
$2K |
| 86769 |
|
186 |
179 |
$2K |
| 85007 |
|
1,236 |
1,061 |
$2K |
| 85651 |
|
1,068 |
933 |
$2K |
| 83521 |
|
188 |
176 |
$2K |
| 86694 |
|
173 |
160 |
$2K |
| 82627 |
|
172 |
166 |
$2K |
| 87529 |
|
93 |
90 |
$2K |
| 86308 |
|
424 |
408 |
$2K |
| 87420 |
|
239 |
210 |
$2K |
| 86304 |
|
145 |
134 |
$2K |
| 85014 |
|
1,465 |
1,300 |
$2K |
| 85660 |
|
339 |
322 |
$2K |
| 87497 |
|
85 |
65 |
$1K |
| 86677 |
|
140 |
132 |
$1K |
| 81420 |
Fetal chromosomal aneuploidy genomic sequence analysis panel |
626 |
411 |
$1K |
| 84432 |
|
151 |
140 |
$1K |
| 80156 |
|
237 |
225 |
$1K |
| 82024 |
|
51 |
51 |
$1K |
| 81000 |
|
715 |
651 |
$1K |
| 84466 |
|
153 |
148 |
$1K |
| 87329 |
|
130 |
124 |
$1K |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
48,633 |
28,288 |
$1K |
| 85732 |
|
196 |
93 |
$1K |
| 84520 |
|
760 |
662 |
$1K |
| 85613 |
|
133 |
94 |
$934.20 |
| 84075 |
|
468 |
421 |
$909.34 |
| 86147 |
|
25 |
24 |
$885.15 |
| 86146 |
|
42 |
41 |
$852.87 |
| 86807 |
|
17 |
15 |
$808.83 |
| 85379 |
|
102 |
100 |
$779.04 |
| 84132 |
|
457 |
404 |
$742.33 |
| 87040 |
|
88 |
57 |
$675.67 |
| 86335 |
|
42 |
38 |
$658.64 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
58 |
57 |
$655.76 |
| 82330 |
|
98 |
84 |
$639.12 |
| 88346 |
|
14 |
13 |
$627.16 |
| 80185 |
|
215 |
182 |
$626.31 |
| 87075 |
|
111 |
105 |
$596.00 |
| 81508 |
|
60 |
57 |
$594.19 |
| 84681 |
|
54 |
49 |
$576.74 |
| 86036 |
|
57 |
56 |
$561.85 |
| 84163 |
|
40 |
40 |
$556.85 |
| 84703 |
|
88 |
85 |
$508.67 |
| 84166 |
|
52 |
50 |
$488.83 |
| 86255 |
|
55 |
52 |
$480.90 |
| 84295 |
|
270 |
241 |
$439.09 |
| 86141 |
|
68 |
64 |
$351.94 |
| 82374 |
|
221 |
202 |
$351.38 |
| 82435 |
|
223 |
203 |
$333.40 |
| 87468 |
|
1,033 |
983 |
$290.95 |
| 84285 |
|
28 |
13 |
$268.71 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
38 |
38 |
$267.66 |
| 86705 |
|
26 |
25 |
$250.63 |
| 87469 |
|
1,030 |
981 |
$250.59 |
| 82952 |
|
104 |
104 |
$250.43 |
| 87207 |
|
41 |
41 |
$239.60 |
| 82985 |
|
31 |
30 |
$231.15 |
| 86870 |
|
18 |
12 |
$229.36 |
| 87206 |
|
87 |
69 |
$219.15 |
| 84270 |
|
13 |
13 |
$218.57 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
402 |
399 |
$203.61 |
| 82378 |
|
13 |
12 |
$192.27 |
| 81329 |
|
584 |
364 |
$191.80 |
| 80051 |
|
58 |
53 |
$148.33 |
| 84630 |
|
14 |
13 |
$148.07 |
| 80184 |
|
28 |
27 |
$125.00 |
| 84590 |
|
14 |
13 |
$115.83 |
| 80299 |
|
15 |
12 |
$111.92 |
| 86592 |
|
26 |
26 |
$89.67 |
| 86015 |
|
14 |
12 |
$82.13 |
| 80162 |
|
71 |
63 |
$66.22 |
| 86593 |
|
13 |
12 |
$44.00 |
| 86021 |
|
14 |
13 |
$42.55 |
| 99001 |
|
2,381 |
2,280 |
$41.12 |
| 87081 |
|
15 |
13 |
$35.84 |
| 87505 |
|
28 |
28 |
$35.20 |
| 81002 |
|
20 |
18 |
$26.83 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
1,671 |
1,647 |
$17.57 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
5,545 |
4,048 |
$4.10 |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
124 |
123 |
$0.00 |
| 80359 |
|
13 |
13 |
$0.00 |
| 87484 |
|
24 |
24 |
$0.00 |
| 80324 |
|
13 |
13 |
$0.00 |